Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.
Jasna Hocevar-Trnka, MD, MPH
Advertisement
Articles by Jasna Hocevar-Trnka, MD, MPH
Advertisement
Latest Updated Articles
RE104: A Novel, Fast-Acting Psychedelic for Postpartum DepressionPublished: June 26th 2024 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
2
Preliminary Report on Dangers of AI Chatbots
3
Closing the Gap in Schizophrenia Care: Insights From the INTEGRATE Guidelines
4
6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia
5
